Sino Biological announced the launch of SwiftFluo® TR-FRET Kinase Assay Kits in January 2026, providing a ready-to-use, high-performance solution for kinase activity detection and inhibitor screening.14
The kits utilize Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, offering superior sensitivity, low background, robust reproducibility, and advantages over traditional methods like radioactive assays, ELISA, and ADP-Glo™ assays.123
Optimized for over 60 tyrosine kinases (TKs), 150 serine/threonine kinases (STKs), and 15 cyclin-dependent kinases (CDKs), including targets like EGFR, FLT3, JAK2, and CDK1.123
Features include wide dynamic range, high signal-to-noise ratio, no-wash homogeneous format, rapid 60-minute results, and compatibility with 96-, 384-, and 1536-well plates for high-throughput screening (HTS).23
Designed for applications in kinase profiling, small molecule drug discovery, lead optimization, and hit validation, with standalone substrates and kinases available.123
Sources:
1. https://www.news-medical.net/news/20260121/Sino-Biologicals-launch-of-SwiftFluoc2ae-TR-FRET-Kits-pioneers-a-new-era-in-high-throughput-kinase-inhibitor-screening.aspx
2. https://www.pharmaceutical-technology.com/products/swiftfluo-tr-fret-kinase-kits/
3. https://www.news-medical.net/whitepaper/20260202/Boost-assay-sensitivity-and-throughput-with-SwiftFluo-TR-FRET-kinase-kits.aspx
4. https://www.scientistlive.com/content/sino-biological-launches-swiftfluo-tr-fret-kinase-assay-kits